DBVT — DBV Technologies S A

Ownership history in MPM BioImpact LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in DBV Technologies S A (DBVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.19% (2025 Q4)
Avg. % of fund
1.86%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 996,825 -57,679 -5.5% 2.19% $19.1M $19.17
2025 Q3 UNCHANGED 1,054,504 — 0% 1.73% $10.5M $10.00
2025 Q2 INITIATED 1,054,504 — — 1.67% $9.6M $9.16
% of Fund (quarterly)    DBVT price (monthly, adj. close)

Other funds also holding DBVT

As of 2025 Q4 — sorted by position size

Vivo Capital, LLC 3Y 7Y 3.05% Yiheng Capital Management, L.P. 3Y 7Y 2.48% Patient Square Capital LP 3Y 1.47% Octagon Capital Advisors LP 3Y 1.34% Siren, L.L.C. 1.06% Redmile Group, LLC 3Y 7Y 0.78% Atika Capital Management LLC 3Y 7Y 0.42% Vestal Point Capital, LP 0.2% Polymer Capital Management (HK) LTD 0.18% BAKER BROS. ADVISORS LP 3Y 7Y 0.16%
← Back to MPM BioImpact LLC Holdings